Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
111 studies found for:    "Pigmentary retinopathy"
Show Display Options
RSS Create an RSS feed from your search for:
"Pigmentary retinopathy"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Procedure: Electro-acupuncture
2 Completed
Has Results
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
Condition: Retinitis Pigmentosa
Interventions: Drug: Lutein;   Dietary Supplement: Cornstarch control
3 Recruiting Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.
Condition: Retinitis Pigmentosa
Intervention:
4 Recruiting Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: levodopa-carbidopa
5 Completed Trial of Oral Valproic Acid for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Valproic Acid;   Drug: Placebo
6 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
7 Recruiting Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial
Condition: Retinitis Pigmentosa
Intervention:
8 Not yet recruiting Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Continuous oxygen;   Device: blue light-absorbing sunglasses;   Drug: Compound thrombosis capsule sig: 1.5g/tid;   Drug: Ginkgo biloba pills sig: 300mg/tid;;   Drug: Vitamin B sig: 10mg/tid;   Drug: Vitamin AD sig: 1 tablet/tid
9 Enrolling by invitation Feasibility and Safety of Adult Human Bone Marrow-derived Mesenchymal Stem Cells by Intravitreal Injection in Patients With Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Other: Intravitreal injection of bone marrow-derived mesenchymal stem cells
10 Completed Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: Vitamin A
11 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
12 Completed Stress and Vision Fluctuations in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention:
13 Recruiting Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum
Condition: Retinitis Pigmentosa
Interventions: Dietary Supplement: Lycium Barbarum;   Dietary Supplement: Placebo
14 Not yet recruiting Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study
Condition: Retinitis Pigmentosa
Intervention: Device: Transcorneal Electrical Stimulation using Okustim device
15 Completed A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: NT-501
16 Completed A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: NT-501
17 Recruiting RST-001 Phase I/II Trial for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: RST-001
18 Unknown  Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: BMMNCs
19 Active, not recruiting Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Device: Electro-acupuncture;   Device: Laser Acupuncture;   Device: Transcorneal Electrical Stimulation;   Device: Sham Electro-acupuncture;   Device: Sham laser acupuncture;   Device: Sham transcorneal electrical stimulation
20 Completed Randomized Trial for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Vitamin A;   Drug: Nutritional Supplement

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.